Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gopa Iyer

Showing results (1-10 of 144) with videos related to

Pageof 15
Sort By:
Urologic Oncology|February 24, 2018
Novel biomarkers in bladder cancerMichael L Cheng, Gopa Iyer
Current Treatment Options in Oncology|September 19, 2018
Low-Grade Serous Ovarian Cancer: Current Treatment Paradigms and Future DirectionsRachel N Grisham, Gopa Iyer
The Urologic Clinics of North America|April 18, 2015
Targeted therapy in advanced bladder cancer: what have we learned?Emmet J Jordan, Gopa Iyer
Current Opinion in Urology|October 1, 2019
The landscape of immunotherapy in metastatic urothelial carcinomaMin Yuen Teo, Gopa Iyer
Surgical Pathology Clinics|November 19, 2018
Updates on the Genetics and Molecular Subtypes of Urothelial Carcinoma and Select VariantsHikmat Al-Ahmadie, Gopa Iyer
Urologic Oncology|January 31, 2012
Fibroblast growth factor receptor-3 in urothelial tumorigenesisGopa Iyer, Matthew I Milowsky
Cancer Treatment and Research Communications|September 13, 2020
Emerging biomarkers in urothelial carcinoma: Challenges and opportunitiesNikolaos Andreatos, Gopa Iyer, Petros Grivas
Cancer Cell|January 12, 2021
Lessons from the Study of Exceptional RespondersArijh Elzein, Gopa Iyer, David B Solit
Expert Review of Anticancer Therapy|November 30, 2010
Novel strategies for treating relapsed/refractory urothelial carcinomaGopa Iyer, Matthew I Milowsky, Dean F Bajorin
Clinical Advances in Hematology & Oncology : H&O|June 14, 2014
Targeted therapies for treatment of recurrent ovarian cancerRachel N Grisham, David M Hyman, Gopa Iyer
Pageof 15

Showing results (1-10 of 144) with videos related to

Sort By:
Pageof 15
Urologic Oncology|February 24, 2018
Novel biomarkers in bladder cancerMichael L Cheng, Gopa Iyer
Current Treatment Options in Oncology|September 19, 2018
Low-Grade Serous Ovarian Cancer: Current Treatment Paradigms and Future DirectionsRachel N Grisham, Gopa Iyer
The Urologic Clinics of North America|April 18, 2015
Targeted therapy in advanced bladder cancer: what have we learned?Emmet J Jordan, Gopa Iyer
Current Opinion in Urology|October 1, 2019
The landscape of immunotherapy in metastatic urothelial carcinomaMin Yuen Teo, Gopa Iyer
Surgical Pathology Clinics|November 19, 2018
Updates on the Genetics and Molecular Subtypes of Urothelial Carcinoma and Select VariantsHikmat Al-Ahmadie, Gopa Iyer
Urologic Oncology|January 31, 2012
Fibroblast growth factor receptor-3 in urothelial tumorigenesisGopa Iyer, Matthew I Milowsky
Cancer Treatment and Research Communications|September 13, 2020
Emerging biomarkers in urothelial carcinoma: Challenges and opportunitiesNikolaos Andreatos, Gopa Iyer, Petros Grivas
Cancer Cell|January 12, 2021
Lessons from the Study of Exceptional RespondersArijh Elzein, Gopa Iyer, David B Solit
Expert Review of Anticancer Therapy|November 30, 2010
Novel strategies for treating relapsed/refractory urothelial carcinomaGopa Iyer, Matthew I Milowsky, Dean F Bajorin
Clinical Advances in Hematology & Oncology : H&O|June 14, 2014
Targeted therapies for treatment of recurrent ovarian cancerRachel N Grisham, David M Hyman, Gopa Iyer
Pageof 15